B-SOFT Co.,Ltd. (SHE:300451)
5.48
-0.09 (-1.62%)
Feb 13, 2026, 3:04 PM CST
B-SOFT Revenue
B-SOFT had revenue of 285.01M CNY in the quarter ending September 30, 2025, a decrease of -35.50%. This brings the company's revenue in the last twelve months to 1.12B, down -31.45% year-over-year. In the year 2024, B-SOFT had annual revenue of 1.42B, down -11.96%.
Revenue (ttm)
1.12B
Revenue Growth
-31.45%
P/S Ratio
7.59
Revenue / Employee
308.72K
Employees
3,614
Market Cap
8.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.42B | -193.23M | -11.96% |
| Dec 31, 2023 | 1.62B | 88.73M | 5.81% |
| Jan 1, 2023 | 1.53B | -371.84M | -19.58% |
| Jan 1, 2022 | 1.90B | 266.14M | 16.30% |
| Dec 31, 2020 | 1.63B | 153.02M | 10.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Tianjin Ringpu Bio-Technology | 3.37B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Edan Instruments | 1.90B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |